DK0590551T3 - Nye terapeutiske anvendelser af phthalazinonderivater - Google Patents

Nye terapeutiske anvendelser af phthalazinonderivater

Info

Publication number
DK0590551T3
DK0590551T3 DK93115512.1T DK93115512T DK0590551T3 DK 0590551 T3 DK0590551 T3 DK 0590551T3 DK 93115512 T DK93115512 T DK 93115512T DK 0590551 T3 DK0590551 T3 DK 0590551T3
Authority
DK
Denmark
Prior art keywords
therapeutic applications
new therapeutic
phthalazine derivatives
derivatives
control
Prior art date
Application number
DK93115512.1T
Other languages
English (en)
Inventor
Juergen Prof Engel
Bernhard Dr Kutscher
Ilona Dr Fleischhauer
Stefan Prof Szelenyi
Peter Dr Metzenauer
Ulrich Dr Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0590551T3 publication Critical patent/DK0590551T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93115512.1T 1992-10-02 1993-09-25 Nye terapeutiske anvendelser af phthalazinonderivater DK0590551T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233113 1992-10-02

Publications (1)

Publication Number Publication Date
DK0590551T3 true DK0590551T3 (da) 1997-04-21

Family

ID=6469448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93115512.1T DK0590551T3 (da) 1992-10-02 1993-09-25 Nye terapeutiske anvendelser af phthalazinonderivater

Country Status (18)

Country Link
US (1) US5556856A (da)
EP (1) EP0590551B1 (da)
JP (1) JP3623975B2 (da)
CN (1) CN1088435A (da)
AT (1) ATE144708T1 (da)
AU (1) AU666773B2 (da)
CA (1) CA2107548A1 (da)
CZ (1) CZ199593A3 (da)
DE (1) DE59304351D1 (da)
DK (1) DK0590551T3 (da)
ES (1) ES2096168T3 (da)
GR (1) GR3022070T3 (da)
HU (1) HUT65353A (da)
MX (1) MX9306120A (da)
RU (1) RU2106143C1 (da)
SK (1) SK104493A3 (da)
UA (1) UA26953C2 (da)
ZA (1) ZA937315B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162616A (en) * 1997-04-16 2000-12-19 Millennium Pharmaceuticals, Inc. Multidrug resistance-associated polypeptide
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
JP2005508990A (ja) * 2001-11-07 2005-04-07 ファルマシア・コーポレーション 真核細胞におけるポリアミドの取込みおよび核蓄積を促進する方法
JP4500161B2 (ja) 2002-04-30 2010-07-14 クドス ファーマシューティカルズ リミテッド フタラジノン誘導体
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
DE602007010118D1 (de) * 2006-04-20 2010-12-09 Glaxo Group Ltd 2-substituierte 4-benzylphthalazinonderivate als histamin-h1- und h3-antagonisten
US20090209520A1 (en) * 2006-06-15 2009-08-20 Kudos Pharmaceuticals Limited 2 -oxybenzamide derivatives as parp inhibitors
CN101484436A (zh) * 2006-06-15 2009-07-15 库多斯药物有限公司 作为parp抑制剂的2-氧基杂芳基酰胺衍生物
JP2009539963A (ja) * 2006-06-15 2009-11-19 クドス ファーマシューティカルズ リミテッド Ｐａｒｐ阻害剤
TWI404716B (zh) 2006-10-17 2013-08-11 Kudos Pharm Ltd 酞嗪酮（ｐｈｔｈａｌａｚｉｎｏｎｅ）衍生物
ES2341813T3 (es) * 2006-12-20 2010-06-28 Glaxo Group Limited 4-bencil-1 (2h)-ftalazinonas como antagonistas del receptor h1.
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
AU2008299721A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
JP2011500537A (ja) * 2007-10-11 2011-01-06 グラクソ グループ リミテッド Ｈ１受容体アンタゴニストとしてのフタラジンおよびピリド［３，４−ｄ］ピリダジン化合物
CN101821242B (zh) 2007-10-17 2013-07-24 库多斯药物有限公司 4-[3-(4-环丙烷羰基-哌嗪-1-羰基)-4-氟-苄基]-2h-酞嗪-1-酮
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
CN102238945B (zh) * 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
TW201114756A (en) * 2009-07-15 2011-05-01 Astrazeneca Ab Phthalazinone compound
CA2906008C (en) 2013-03-13 2019-07-09 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222191B1 (de) * 1985-11-11 1991-01-30 ASTA Pharma AG 4-Benzyl-1-(2H)-phthalazinon-Derivate
JPH0667844B2 (ja) * 1987-03-06 1994-08-31 エーザイ株式会社 虚血性心疾患の治療・予防剤
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis

Also Published As

Publication number Publication date
ZA937315B (en) 1994-04-22
EP0590551A2 (de) 1994-04-06
DE59304351D1 (de) 1996-12-05
RU2106143C1 (ru) 1998-03-10
EP0590551B1 (de) 1996-10-30
AU4876993A (en) 1994-04-14
ES2096168T3 (es) 1997-03-01
SK104493A3 (en) 1994-08-10
MX9306120A (es) 1994-04-29
ATE144708T1 (de) 1996-11-15
CA2107548A1 (en) 1994-04-03
JP3623975B2 (ja) 2005-02-23
HUT65353A (en) 1994-05-02
EP0590551A3 (da) 1994-08-31
HU9302784D0 (en) 1993-12-28
US5556856A (en) 1996-09-17
GR3022070T3 (en) 1997-03-31
CN1088435A (zh) 1994-06-29
CZ199593A3 (en) 1994-04-13
AU666773B2 (en) 1996-02-22
JPH06312928A (ja) 1994-11-08
UA26953C2 (uk) 1999-12-29

Similar Documents

Publication Publication Date Title
DK0590551T3 (da) Nye terapeutiske anvendelser af phthalazinonderivater
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
ATE211743T1 (de) Substituierte 3-aminochinuclidine
NO148643C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 1-(1,3-dixolan-2-ylmetyl)-1h-imidazoler og-1h-1,2,4-triazoler
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
RU93056139A (ru) Производные фталазинона, обладающие противоаритмической и анальгетической активностью, а также способностью преодолевать мультилекарственную устойчивость
DK0378086T3 (da) Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme
DK0572852T3 (da) Quinoxalin-2,3-(1H,4H)-dioner som lægemiddel
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
DK0480155T3 (da) 4-Substituerede dihydropyrido(4,3-d)pyrimidiner som analgetica og topiske antiinflammatoriske midler til behandling af hudlidelser
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
DE69228307D1 (de) Imidazo(1,2-c)chinazolinderivate als antihypertensive und antidysurie
EP0535250A4 (en) Novel compounds and use thereof as medicine
NO893784L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
FR2701479B1 (fr) Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
NO162468C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater.
NO170282C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater
BR9306388A (pt) Polipetídios bloqueadores dos canais de cálcio derivados de filistata hibernalis
NO891025D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive sialosylglycerider.